Podcast: Non-binding Guidance: SEC Disclosure Issues for Life Sciences Companies
On June 5, 2024, a three judge panel of the U.S. Fifth Circuit Court of Appeals unanimously struck down the Securities and Exchange Commission’s (“SEC”) final rule, which created onerous restrictions for managers of private...more